{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:46:47Z","timestamp":1788965207026,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA210087"],"award-info":[{"award-number":["CA210087"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA265095"],"award-info":[{"award-number":["CA265095"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA163205"],"award-info":[{"award-number":["CA163205"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NS106170"],"award-info":[{"award-number":["NS106170"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI129582"],"award-info":[{"award-number":["AI129582"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA247550"],"award-info":[{"award-number":["CA247550"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA264512"],"award-info":[{"award-number":["CA264512"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA266457"],"award-info":[{"award-number":["CA266457"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["CA223400"],"award-info":[{"award-number":["CA223400"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68582-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:14:43Z","timestamp":1770254083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1171-4070","authenticated-orcid":false,"given":"Zhenlong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3983-5908","authenticated-orcid":false,"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4095-3020","authenticated-orcid":false,"given":"Michael A.","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-3223","authenticated-orcid":false,"given":"Jianhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"68582_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian, H. et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 11, 41 (2021).","journal-title":"Blood Cancer J."},{"key":"68582_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645\u2013648 (1994).","journal-title":"Nature"},{"key":"68582_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med 3, 730\u2013737 (1997).","journal-title":"Nat. Med"},{"key":"68582_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng, S. W. et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature 540, 433\u2013437 (2016).","journal-title":"Nature"},{"key":"68582_CR5","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1182\/blood-2009-02-206565","volume":"115","author":"DC Taussig","year":"2010","unstructured":"Taussig, D. C. et al. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 115, 1976\u20131984 (2010).","journal-title":"Blood"},{"key":"68582_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1172\/JCI41495","volume":"121","author":"JE Sarry","year":"2011","unstructured":"Sarry, J. E. et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2R\u03b3c-deficient mice. J. Clin. Invest 121, 384\u2013395 (2011).","journal-title":"J. Clin. Invest"},{"key":"68582_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ni1080","volume":"5","author":"KJ Hope","year":"2004","unstructured":"Hope, K. J., Jin, L. & Dick, J. E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5, 738\u2013743 (2004).","journal-title":"Nat. Immunol."},{"key":"68582_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","volume":"19","author":"N Goardon","year":"2011","unstructured":"Goardon, N. et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138\u2013152 (2011).","journal-title":"Cancer Cell"},{"key":"68582_CR9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1084\/jem.20151775","volume":"213","author":"L Quek","year":"2016","unstructured":"Quek, L. et al. Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage. J. Exp. Med 213, 1513\u20131535 (2016).","journal-title":"J. Exp. Med"},{"key":"68582_CR10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nbt1350","volume":"25","author":"F Ishikawa","year":"2007","unstructured":"Ishikawa, F. et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315\u20131321 (2007).","journal-title":"Nat. Biotechnol."},{"key":"68582_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41590-022-01213-2","volume":"23","author":"ER Kansler","year":"2022","unstructured":"Kansler, E. R. et al. Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies. Nat. Immunol. 23, 904\u2013915 (2022).","journal-title":"Nat. Immunol."},{"key":"68582_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","volume":"171","author":"OE Weizman","year":"2017","unstructured":"Weizman, O. E. et al. ILC1 Confer Early Host Protection at Initial Sites of Viral Infection. Cell 171, 795\u2013808.e712 (2017).","journal-title":"Cell"},{"key":"68582_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.immuni.2019.11.004","volume":"52","author":"T Nabekura","year":"2020","unstructured":"Nabekura, T., Riggan, L., Hildreth, A. D., O\u2019Sullivan, T. E. & Shibuya, A. Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-\u03b3 Secretion for Upregulating Bcl-xL Expression in Hepatocytes. Immunity 52, 96\u2013108.e109 (2020).","journal-title":"Immunity"},{"key":"68582_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-022-05297-6","volume":"611","author":"AM Tsou","year":"2022","unstructured":"Tsou, A. M. et al. Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces. Nature 611, 787\u2013793 (2022).","journal-title":"Nature"},{"key":"68582_CR15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41586-022-05395-5","volume":"611","author":"KJ Jarick","year":"2022","unstructured":"Jarick, K. J. et al. Non-redundant functions of group 2 innate lymphoid cells. Nature 611, 794\u2013800 (2022).","journal-title":"Nature"},{"key":"68582_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2018.05.014","volume":"174","author":"C Schneider","year":"2018","unstructured":"Schneider, C. et al. A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell 174, 271\u2013284.e214 (2018).","journal-title":"Cell"},{"key":"68582_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1126\/science.aaz8777","volume":"375","author":"N Serafini","year":"2022","unstructured":"Serafini, N. et al. Trained ILC3 responses promote intestinal defense. Science 375, 859\u2013863 (2022).","journal-title":"Science"},{"key":"68582_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41586-022-05141-x","volume":"610","author":"M Lyu","year":"2022","unstructured":"Lyu, M. et al. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut. Nature 610, 744\u2013751 (2022).","journal-title":"Nature"},{"key":"68582_CR19","doi-asserted-by":"publisher","unstructured":"Horn, V. & Sonnenberg, G. F. Group 3 innate lymphoid cells in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1038\/s41575-024-00906-3 (2024).","DOI":"10.1038\/s41575-024-00906-3"},{"key":"68582_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41577-022-00704-5","volume":"22","author":"H Spits","year":"2022","unstructured":"Spits, H. & Mj\u00f6sberg, J. Heterogeneity of type 2 innate lymphoid cells. Nat. Rev. Immunol. 22, 701\u2013712 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"68582_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","volume":"23","author":"N Jacquelot","year":"2022","unstructured":"Jacquelot, N., Seillet, C., Vivier, E. & Belz, G. T. Innate lymphoid cells and cancer. Nat. Immunol. 23, 371\u2013379 (2022).","journal-title":"Nat. Immunol."},{"key":"68582_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2023.12.015","volume":"187","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. Cell 187, 624\u2013641.e623 (2024).","journal-title":"Cell"},{"key":"68582_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","volume":"41","author":"A Diefenbach","year":"2014","unstructured":"Diefenbach, A., Colonna, M. & Koyasu, S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 41, 354\u2013365 (2014).","journal-title":"Immunity"},{"key":"68582_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","volume":"17","author":"CS Klose","year":"2016","unstructured":"Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765\u2013774 (2016).","journal-title":"Nat. Immunol."},{"key":"68582_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ni.1962","volume":"12","author":"H Spits","year":"2011","unstructured":"Spits, H. & Di Santo, J. P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21\u201327 (2011).","journal-title":"Nat. Immunol."},{"key":"68582_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.4049\/jimmunol.2000750","volume":"207","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Purinergic receptor P2Y(6) is a negative regulator of nk cell maturation and function. J. Immunol. 207, 1555\u20131565 (2021).","journal-title":"J. Immunol."},{"key":"68582_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540\u2013544 (2010).","journal-title":"Nature"},{"key":"68582_CR28","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464, 1367\u20131370 (2010).","journal-title":"Nature"},{"key":"68582_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.immuni.2012.10.003","volume":"37","author":"GF Sonnenberg","year":"2012","unstructured":"Sonnenberg, G. F. & Artis, D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 37, 601\u2013610 (2012).","journal-title":"Immunity"},{"key":"68582_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41577-023-00906-5","volume":"24","author":"J Abramson","year":"2024","unstructured":"Abramson, J., Dobe\u0161, J., Lyu, M. & Sonnenberg, G. F. The emerging family of ROR\u03b3t(+) antigen-presenting cells. Nat. Rev. Immunol. 24, 64\u201377 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"68582_CR31","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1016\/j.cell.2021.07.029","volume":"184","author":"J Goc","year":"2021","unstructured":"Goc, J. et al. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell 184, 5015\u20135030.e5016 (2021).","journal-title":"Cell"},{"key":"68582_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045\u20131054 (2011).","journal-title":"Nat. Immunol."},{"key":"68582_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41590-022-01198-y","volume":"23","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. ILC1s control leukemia stem cell fate and limit development of AML. Nat. Immunol. 23, 718\u2013730 (2022).","journal-title":"Nat. Immunol."},{"key":"68582_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41422-020-00445-x","volume":"31","author":"L Mazzurana","year":"2021","unstructured":"Mazzurana, L. et al. Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing. Cell Res. 31, 554\u2013568 (2021).","journal-title":"Cell Res."},{"key":"68582_CR35","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.3324\/haematol.2014.119602","volume":"100","author":"S Trabanelli","year":"2015","unstructured":"Trabanelli, S. et al. CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis. Haematologica 100, e257\u2013e260 (2015).","journal-title":"Haematologica"},{"key":"68582_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107728","volume":"26","author":"M Falquet","year":"2023","unstructured":"Falquet, M. et al. Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations. iScience 26, 107728 (2023).","journal-title":"iScience"},{"key":"68582_CR37","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/s41590-024-01885-y","volume":"25","author":"N Jaeger","year":"2024","unstructured":"Jaeger, N. et al. Diversity of group 1 innate lymphoid cells in human tissues. Nat. Immunol. 25, 1460\u20131473 (2024).","journal-title":"Nat. Immunol."},{"key":"68582_CR38","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet, L. et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat. Immunol. 25, 1474\u20131488 (2024).","journal-title":"Nat. Immunol."},{"key":"68582_CR39","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang, F. et al. A pan-cancer single-cell panorama of human natural killer cells. Cell 186, 4235\u20134251.e4220 (2023).","journal-title":"Cell"},{"key":"68582_CR40","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3324\/haematol.2016.143180","volume":"101","author":"YS Al-Matary","year":"2016","unstructured":"Al-Matary, Y. S. et al. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner. Haematologica 101, 1216\u20131227 (2016).","journal-title":"Haematologica"},{"key":"68582_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","volume":"122","author":"F Mussai","year":"2013","unstructured":"Mussai, F. et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 122, 749\u2013758 (2013).","journal-title":"Blood"},{"key":"68582_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.692800","volume":"9","author":"KE Miari","year":"2021","unstructured":"Miari, K. E., Guzman, M. L., Wheadon, H. & Williams, M. T. S. Macrophages in acute myeloid leukaemia: significant players in therapy resistance and patient outcomes. Front Cell Dev. Biol. 9, 692800 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"68582_CR43","first-page":"3074","volume":"93","author":"H Kiyoi","year":"1999","unstructured":"Kiyoi, H. et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93, 3074\u20133080 (1999).","journal-title":"Blood"},{"key":"68582_CR44","first-page":"7233","volume":"61","author":"SP Whitman","year":"2001","unstructured":"Whitman, S. P. et al. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res 61, 7233\u20137239 (2001).","journal-title":"Cancer Res"},{"key":"68582_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","volume":"46","author":"Y Simoni","year":"2017","unstructured":"Simoni, Y. et al. Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46, 148\u2013161 (2017).","journal-title":"Immunity"},{"key":"68582_CR46","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.immuni.2021.07.019","volume":"54","author":"DC Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez, D. C. et al. An in vitro platform supports generation of human innate lymphoid cells from CD34(+) hematopoietic progenitors that recapitulate ex vivo identity. Immunity 54, 2417\u20132432.e2415 (2021).","journal-title":"Immunity"},{"key":"68582_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie, D., Helgason, G. V. & Copland, M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat. Rev. Cancer 20, 158\u2013173 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"68582_CR48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach, P. & Trumpp, A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108, 353\u2013366 (2023).","journal-title":"Haematologica"},{"key":"68582_CR49","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas, D. & Majeti, R. Biology and relevance of human acute myeloid leukemia stem cells. Blood 129, 1577\u20131585 (2017).","journal-title":"Blood"},{"key":"68582_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8522","volume":"9","author":"I Weinh\u00e4user","year":"2023","unstructured":"Weinh\u00e4user, I. et al. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism. Sci. Adv. 9, eadf8522 (2023).","journal-title":"Sci. Adv."},{"key":"68582_CR51","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.immuni.2017.05.001","volume":"46","author":"JH Bernink","year":"2017","unstructured":"Bernink, J. H., Mj\u00f6sberg, J. & Spits, H. Human ILC1: To Be or Not to Be. Immunity 46, 756\u2013757 (2017).","journal-title":"Immunity"},{"key":"68582_CR52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink, J. H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221\u2013229 (2013).","journal-title":"Nat. Immunol."},{"key":"68582_CR53","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.stem.2024.03.018","volume":"31","author":"Z Shah","year":"2024","unstructured":"Shah, Z. et al. Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer. Cell Stem Cell 31, 803\u2013817.e806 (2024).","journal-title":"Cell Stem Cell"},{"key":"68582_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","volume":"23","author":"Y Li","year":"2018","unstructured":"Li, Y., Hermanson, D. L., Moriarity, B. S. & Kaufman, D. S. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. Cell Stem Cell 23, 181\u2013192.e185 (2018).","journal-title":"Cell Stem Cell"},{"key":"68582_CR55","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.leu.2400756","volume":"11","author":"H Kiyoi","year":"1997","unstructured":"Kiyoi, H. et al. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia 11, 1447\u20131452 (1997).","journal-title":"Leukemia"},{"key":"68582_CR56","doi-asserted-by":"publisher","DOI":"10.12659\/MSMBR.937446","volume":"28","author":"N Ei Ei Aung","year":"2022","unstructured":"Ei Ei Aung, N., Yamsri, S., Teawtrakul, N., Kamsaen, P. & Fucharoen, S. FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand. Med Sci. Monit. Basic Res 28, e937446 (2022).","journal-title":"Med Sci. Monit. Basic Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68582-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68582-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:09:01Z","timestamp":1773328141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68582-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68582"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68582-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2319959\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2377"}}